Form 4: Disc Medicine CEO John Quisel Sells Shares to Cover Tax Obligations

CEO of Disc Medicine, John Quisel, sold shares to cover tax obligations related to vesting restricted stock units.

Summary

• On February 18, 2025, John Quisel, CEO of Disc Medicine, Inc. (IRON), sold 5,574 shares of common stock at a price of $54.58 per share.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units granted on January 10, 2024.
• Following the transaction, Quisel directly owns 154,828 shares of Disc Medicine, Inc.

Sentiment

Score: 6

Explanation: The document describes a routine transaction (sell to cover) and doesn't inherently indicate positive or negative sentiment. It's a neutral event from an investment perspective.

Management Comments

• The sale is a 'sell to cover' transaction and does not represent a discretionary transaction by the Reporting Person.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among company executives and do not necessarily indicate a negative outlook on the company's future.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.

Key Dates

Keywords

Disc Medicine, IRON, John Quisel, SEC Form 4, Stock Sale, Tax Obligations, Restricted Stock Units, Insider Trading